Biomarker Diagnostics Panel Discussion (from common to rare cancers)
Availability
On-Demand
Cost
$0.00
Credit Offered
No Credit Offered

NEW On-Demand Webinar - released September 2026

The Florida Society of Pathologists (FSP) invites you to watch an important and timely on-demand webinar focused on Biomarker Diagnostics from common to rare cancers – from the perspective of diagnostic and pharma companies.  This panel discussion was originally given during the FSP Precision Medicine Symposium that was held in August 2026 at Moffitt Cancer Center.  

There is no CME for this recorded webinar. 

Moderator: Qihui “Jim” Zhai, MD, FCAP
Panelist 1: Tamara Gilroy (Johnson & Johnson)
Panelist 2: Joshua P Klopper, Medical Director, Endocrinology (Veracyte)
Panelist 3: Dr. Nathan Montgomery (NeoGenomics)
Panelist 4: Katy Wong, PhD (Foundation Medicine)
Panelist 5: Jaclyn Hechtman (Caris Life Sciences)
Panelist 6: Alexander Arrow, MD, CFA (Virchow Medical, Inc)